Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type

Cancer Chemotherapy and Pharmacology

Volumn 66, Issue 4, 2010, Pages 773-783

  Tuan, Tsung Fan ^a,b   Tsai, Meng Li ^c   Yeh, Kai Chia ^a   Huang, Hsin Chieh ^a   Chung, Cheng Ta ^a,d   Huang, Chen Lung ^a   Han, Chia Hung ^a   Chen, Ching Ping ^a   Wang, Min Hsien ^a   Shen, Chien Chang ^a   Lai, Yiu Kay ^d   Lee, Wen Sen ^b   Hwang, Ling Ling ^a,b   Chen, Chiung Tong ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL ILAN UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; Metastasis; Paclitaxel; Stomach; Taxol

Indexed keywords

GREEN FLUORESCENT PROTEIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LAPAROTOMY; LIVER METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PERIOPERATIVE PERIOD; PERITONEAL CAVITY; PERITONEUM METASTASIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH; CANCER GROWTH; CELL INVASION; CONCENTRATION RESPONSE; DISSEMINATED CANCER; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PERITONEUM; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GREEN FLUORESCENT PROTEINS; HUMANS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; PACLITAXEL; PERITONEUM; STOMACH NEOPLASMS; TRANSFECTION;

EID: 78149301777     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1222-3     Document Type: Article

References (48)

1. Archie V, Kauh J, Jones DV Jr, Cruz V, Karpeh MS Jr, Thomas CR Jr (2006) Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol 57:123-131
2. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467-477
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
4. Parkin DM (2002) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044
5. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592
6. Vital statistics in Japan (1950-2007). Vital and Health Statistics Division, Statistics and Information Department, Ministry of Health, Labour and Welfare
7. Yeh KH, Cheng AL (2004) Recent advances in therapy for gastric cancer. J Formos Med Assoc 103:171-185
8. Kodera Y, Fujiwara M, Koike M, Nakao A (2006) Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol 12:2000-2005
9. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis, Eisner MP, Stinchcomb DG, Edwards BK (2008) SEER Cancer statistics review, 1975-2006. National Cancer Institute, Bethesda
10. Lee KH, Lee JH, Cho JK, Kim TW, Kang YK, Lee JS, Kim WK, Chung JG, Lee IC, Sun HS (2001) A prospective correlation of Laurén's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometry. Pathol Res Pract 197:223-229
11. The EUROCARE-4 database on cancer survival in Europe [http://www. eurocare.it/Results/tabid/79/Default.aspx#eu4dB]
12. Hoffman RM (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17:343-359
13. Fidler IJ, Naito S, Pathak S (1990) Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metastasis Rev 9:149-165
14. Khanna C, Jaboin JJ, Drakos E, Tsokos M, Thiele CJ (2002) Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In Vivo 16:77-85
15. Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004-1014
16. Kumar N (1981) Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 256:10435-10441
17. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P'eng FK, Chi CW (1996) Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77:14-18
18. Van Cutsem E (2004) The treatment of advanced gastric cancer: new findings on the activity of the taxanes. Oncologist 9 (suppl 2):9-15
19. Wöhrer SS, Raderer M, Hejna M (2004) Palliative chemotherapy for advanced gastric cancer. Ann Oncol 15:1585-1595
20. Khamly K, Jefford M, Michael M, Zalcberg J (2006) Recent developments in the systemic therapy of advanced gastroesophageal malignancies. Expert Opin Invest Drugs 15:131-153
21. Ohashi N, Kodera Y, Nakanishi H, Yokoyama H, Fujiwara M, Koike M, Hibi K, Nakao A, Tatematsu M (2005) Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol 27:637-644
22. Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M (2006) Follow-up of gastric cancer: a review. Gastric Cancer 9:74-81
23. Soma D, Kitayama J, Ishigami H, Kaisaki S, Nagawa H (2009) Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration. J Surg Res 155:142-146
24. Li WT, Hwang DR, Chen CP, Shen CW, Huang CL, Chen TW, Lin CH, Chang YL, Chang YY, Lo YK, Tseng HY, Lin CC, Song JS, Chen HC, Chen SJ, Wu SH, Chen CT (2003) Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents. J Med Chem 46:1706-1715
25. Huang YC, Chen CT, Chen SC, Lai PH, Liang HC, Chang Y, Yu LC, Sung HW (2005) A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 22:636-646
26. Chuu JJ, Liu JM, Tsou MH, Huang CL, Chen CP, Wang HS, Chen CT (2007) Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas. J Biomed Sci 14:233-244
27. Wu MS, Yang KC, Shun CT, Hsiao TJ, Lin CC, Wang HP, Chuang SM, Lee WJ, Lin JT (1997) Distinct clinicopathologic characteristics of diffuse-and intestinal-type gastric cancer in Taiwan. J Clin Gastroenterol 25:646-649
28. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
29. Kuroda T, Ito M, Wada Y, Kitadai Y, Tanaka S, Yoshida K, Yoshihara M, Haruma K, Merdh S, Chayama K (2008) Presence of poorly differentiated component correlated with submucosal invasion in the early diffuse-type gastric cancer. Hepatogastroenterology 55:2264-2268
30. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265-272
31. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y, Hirohashi S (2005) Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 96:323-332
32. Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T (2008) A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clin Exp Metastasis 25:517-529
33. Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM (2007) Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 5:1001-1014
34. Gumireddy K, Sun F, Klein-Szanto AJ, Gibbins JM, Gimotty PA, Saunders AJ, Schultz PG, Huang Q (2007) In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci USA 104:6696-6701
35. Hoffman R (2002) Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol 3:546-556
36. Yokozaki H (2000) Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 50:767-777
37. John A, Tuszynski G (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7:14-23
38. Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Miyagi Y, Morinaga S, Noguchi Y, Yamamoto Y (2006) Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Hepatogastroenterology 53:964-967
39. Watanabe T, Fujii T, Oya T, Horikawa N, Tabuchi Y, Takahashi Y, Morii M, Takeguchi N, Tsukada K, Sakai H (2009) Involvement of aquaporin-5 in differentiation of human gastric cancer cells. J Physiol Sci 59:113-122
40. Tanigawa N, Morimoto H (1991) Significance of surgical adjuvant chemotherapy for gastric cancer. J Surg Oncol 46:203-207
41. Wu CW, Lo SS, Shen KH, Hsieh MC, Chen JH, Chiang JH, Lin HJ, Li AF, Lui WY (2003) Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg 27:153-158
42. Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S (2007) Multivariate prognostic study on large gastric cancer. J Surg Oncol 96:14-18
43. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H et al (1994) A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5:609-616
44. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M (1997) Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15:261-267
45. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20:1996-2004 (Pubitemid 34413593)
46. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA (2000) Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18:2648-2657
47. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl Med J 355:11-20
48. Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M, Italian Oncology Group for Cancer Research (2008) Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 100:388-398